Free Trial

Sensei Biotherapeutics (SNSE) SEC Filings & 10K Form

Sensei Biotherapeutics logo
$0.53 0.00 (0.00%)
Closing price 03:55 PM Eastern
Extended Trading
$0.52 -0.01 (-1.70%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sensei Biotherapeutics SEC Filings

DateFilerForm TypeView
12/23/2024
3:15 PM
Craver Josiah (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:15 PM
Sensei Biotherapeutics (Issuer)
van der Horst Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:15 PM
Krebs Stephanie (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
7:03 AM
Sensei Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
6:35 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:30 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:36 PM
Craver Josiah (Reporting)
Sensei Biotherapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2024
3:31 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:30 PM
Sensei Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:36 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:31 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:01 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
4:06 PM
Humer Kristian (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:07 PM
English Jessie (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:08 PM
Holmen Bob (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:10 PM
Peyer James (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
4:11 PM
Cambrian BioPharma Inc (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:45 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
6:31 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:10 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:37 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:35 PM
Sensei Biotherapeutics (Filer)
Form DEFA14A
04/29/2024
3:40 PM
Sensei Biotherapeutics (Filer)
Form ARS
04/12/2024
3:31 PM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
6:45 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
5:00 PM
Newtyn Management, LLC (Filed by)
Sensei Biotherapeutics (Subject)
Form SC 13D/A
02/29/2024
3:44 PM
Sensei Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
6:31 AM
Sensei Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
5:25 PM
Colgan Erin (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:28 PM
Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:37 PM
Sensei Biotherapeutics (Issuer)
van der Horst Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:34 PM
Newtyn Management, LLC (Filed by)
Sensei Biotherapeutics (Subject)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SNSE) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners